News

Worldwide pharmaceutical companies look to advance the development of molecules from the laboratory to the clinic and then market them as soon as possible. All this must go on to unfold sans sacrificing the quality of the product, efficiency...

It has indeed been a roller coaster ride for the biopharmaceutical sector ever since the pandemic-led surge in 2020. Since 2023, the resurgence when it comes to mergers and acquisitions has also gone on to signal a significant uptick...

The worldwide biopharmaceutical market is all set to have prominent growth, with the value anticipated to reach $566 billion by 2032, which is up from $263 billion in 2022, thereby reflecting a CAGR of almost 8% from 2023 to...

As per a new Axendia Market Research Report: The State of Generative AI in Life Sciences: The Good, the Bad, and the Ugly, among the pharmaceutical DX-digital transformation pros, 67% went on to answer- not ready when asked about...

It is well to be noted that the worldwide biopharmaceutical CMO as well as CRO market is anticipated to witness quite significant growth in the next decade. The market, which happens to be valued at $34 billion in 2023,...

It is worth noting that the new Australian Institute for Infectious Diseases- AIID has been established so as to bring together some of the country’s greatest scientific as well as medical research minds in order to offer a quick...

In May 2024, the Ramaciotti Centre for Cryo-Electron Microscopy went on to launch the Titan Krios G4 microscope, a state-of-the-art instrument that happens to be one of the most advanced microscopes from Australia. It is well to be noted that...